Cerebral Oxygen Metabolism in Children
Washington University School of Medicine · NCT04157179
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 3–50 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 350
- US sites recruiting
- 1
- Study start
- October 17, 2019
- Record last updated
- September 11, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this research study is to better understand how blood flow and metabolism change can influence brain development in the early decades of life.
We will examine brain blood flow and metabolism using magnetic resonance imaging (MRI). The brain's blood vessels expand and constrict to regulate blood flow based on the brain's needs. The amount of expanding and contracting the blood vessels can do varies by age. The brain's blood flow changes in small ways during everyday activities, such as normal brain growth, exercise, or deep concentration. Significant illness or psychological stress may increase the brain's metabolic demand or cause other bigger changes in blood flow. If blood vessels are not able to expand to give more blood flow when metabolic demand is high, the brain may not get all of the oxygen it needs. In extreme circumstances, if the brain is unable to get enough oxygen for a long time, a stroke may occur. Sometimes small strokes occur without other noticeable changes and are only detectable on an MRI. These are sometimes called "silent strokes." In less extreme circumstances, not having as much oxygen as it wants may cause the brain to grow and develop more slowly than it should.
One way to test the ability of blood vessels to expand is by measuring blood flow while breathing in carbon dioxide. Carbon dioxide causes blood vessels in the brain to dilate without increasing brain metabolism.
During this study participants may be asked to undergo a blood draw, MRI, and potential neuropsychological assessments. It is also possible that the study team will use a special mask to control the amount of carbon dioxide the participants breathe in so they don't breathe in too much.
Being studied: Carbon Dioxide
Conditions: Sickle Cell Disease; Cerebral Stroke
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Healthy Controls
- Healthy controls ages 3-50 years of age
- Able to participate in MRI scan without sedation
- Not currently pregnant
- No significant psychiatric history, defined as having a severe psychiatric diagnosis, per PI discretion
- No history of epilepsy
- No history of stroke or cerebrovascular disease
- May have occasional headaches if not taking a daily preventative medication for headaches
- Not on vasodilatory medication, such as sildenafil or verapamil
Sickle Cell Anemia Participants
- Ages 3-50 years of age
- Hb SS or SBeta-thal
- Able to participate in MRI scan without sedation
- Not currently pregnant
- Not on vasodilatory medication, such as sildenafil or verapamil
Extracorporeal Membrane Oxygenation (ECMO) Survivors:
- Ages 3-50 years of age
- History of cannulation for ECMO
- Able to participate in MRI scan without sedation
- Not currently pregnant
- Not on vasodilatory medication, such as sildenafil or verapamil
Recruiting US locations
Washington University of St. Louis
St Louis, MO 63110
Site contact: Kristin Guilliams, MD · 3144546120 · kristinguilliams@wustl.edu
Study contacts (from the official record)
- Kristin Guilliams, MD · 3144546120 · kristinguilliams@wustl.edu
Similar studies in Missouri
All neurology studies in Missouri →- RecruitingHealthy volunteersEarly Phase 1
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
University of Pennsylvania
- Location
- St Louis, MO + 2 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- St Louis, MO + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Biohaven Therapeutics Ltd.
- Location
- Chesterfield, MO + 24 other US sites
- Eligibility basics
- Ages 40–80
- Recruiting
Diagnosing Epilepsy To EffeCT Change
Epiminder America, Inc.
- Location
- St Louis, MO + 21 other US sites
- Eligibility basics
- Ages 18–75